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Abstract
The plasmid-encoded quinolone resistance gene qnrS1 was recently found to be commonly associated with ciprofloxacin
resistance in Nigeria. We mapped the qnrS1 gene from an Escherichia coli isolate obtained in Nigeria to a 43.5 Kb IncX2
plasmid. The plasmid, pEBG1, was sufficient to confer ciprofloxacin non-susceptibility, as well as tetracycline and
trimethoprim resistance, on E. coli K-12. Deletion analysis confirmed that qnrS1 accounted for all the ciprofloxacin non-
suceptibility conferred by pEBG1 and tetracycline and trimethoprim resistance could be attributed to tetAR and dfrA14
genes respectively. While it contained a complete IncX conjugation system, pEBG1 was not self-transmissible likely due to
an IS3 element inserted between the pilX5 and pilX6 genes. The plasmid was however efficiently mobilizable. pEBG1 was
most similar to another qnrS1-bearing IncX2 plasmid from Nigeria, but both plasmids acquired qnrS1 independently and
differ in their content of other resistance genes. Screening qnrS1–positive isolates from other individuals in Nigeria revealed
that they carried neither pEBG1 nor pNGX2-QnrS1 but that IncX plasmids were prevalent. This study demonstrates that the
IncX backbone is a flexible platform that has contributed to qnrS1 dissemination in Nigeria.
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Introduction
When antibacterial quinolones were first introduced into clinical
practice, it was thought that resistance would be slow to appear
and that transmissible resistance was improbable [1]. Initial
reports of quinolone resistance were due to point mutations in the
genes encoding their gyrase and topoisomerase targets that made
them less sensitive to the drug. In 1998, Martinez-Martinez et al
[2] described a plasmid-borne gene, now termed qnrA, which
conferred four-to-sixteen-fold resistance to quinolones on Entero-
bacteriaceae. qnrA is a pentapeptide repeat protein that protects
DNA gyrase from quinolone binding and inhibition [3]. Other qnr
genes have since been reported and many can be transmitted
horizontally. Transmissible quinolone resistance is also attribut-
able to genes encoding plasmid-encoded efflux pumps, such as
qepA and oqx and, in the case of ciprofloxacin, the acetylating
enzyme aac(69)-Ib-cr. While plasmid-encoded quinolone-resis-
tance genes generally confer low-level resistance, their overall
impact is great because they shield otherwise susceptible bacteria
from the lethal effects of the quinolones, allowing them greater
time and opportunity to evolve higher-level resistance.
Until recently, reports of quinolone resistance were almost non-
existent from West Africa [4]. However, in the past decade Nigeria
has seen a very rapid increase in fluoroquinolone use, due to the
recent expiration of patents protecting ciprofloxacin and perflox-
acin. Introduction of ciprofloxacin into Nigerian clinics was
temporally associated with a significant rise in resistance among
gut commensals. Five years after fluoroquinolones were intro-
duced in a community in Western Nigeria, Escherichia coli strains
showing quinolone-specific resistance mechanisms were isolated
[5]. Although the majority of these isolates carried point-mutations
in the quinolone-resistance determining regions of gyrA and parC,
six strains bore the plasmid-encoded resistance gene qnrS1. In this
study, we characterized a mobile element from one of these
isolates in order to understand the mode of qnrS1 dissemination in
Western Nigeria.
Methods
Strains
Strain 09/22a and other qnrS1-bearing E. coli strains used in
this study were isolated in 2009 during an earlier survey of
quinolone resistance [5]. Other strains used in this study are listed
in Table 1. Strains were maintained at 270uC in Luria broth:
glycerol 1:1.
General molecular biology procedures
Genomic DNA was extracted using the Promega Wizard kit.
Small-scale extractions of large, naturally occurring plasmids were
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carried out by a modified boiling protocol as described previously
[6]. A Qiagen miniprep kit was used to extract smaller
recombinant plasmids. Large scale preparations of plasmids over
20 Kb in size were prepared after growth in terrific broth and
induction with chloramphenicol [7] using the Qiagen large
construct kit. Plasmids were electroporated into E. coli host strains
using a Biorad micropulser according to manufacturers’ instruc-
tions. DNA amplification was performed using Platinum PCR
Supermix (Invitrogen) and 1 mM oligonucleotide primer in each
reaction. Oligonucleotide primer sequences are listed in Table 2.
All amplifications began with a two-minute hot start at 94uC
followed by 30 cycles of denaturing at 94uC for 30 s, annealing at
5uC below primer annealing temperature for 30 s, and extending
at 72uC for one minute per kilobase of DNA. When the target
PCR product was over 3 Kb, we used Pfx polymerase (Invitrogen)
in accordance with manufacturer’s instructions, with annealing at
5uC below the temperature used for Taq PCRs. Where necessary,
for sequencing, PCR amplicons were TA cloned into the pGEM-T
Easy vector (Promega) according to manufacturer’s directions and
plasmids were transformed into chemically competent E. coli K-12
TOP10 cells. For expression, amplicons were cloned into pBAD/
Thio-TOPO (Invitrogen) and induced with 0.2% arabinose.
Expression was verified by western blotting. All plasmids used or
constructed in the course of this study are listed in Table 3. Other
molecular biology operations were performed using standard
procedures [8].
Shot-gun sequencing and sequence analysis
Whole-replicon shotgun library preparation, Sanger sequencing
and assembly of a large plasmid were performed by SeqWright
DNA Technology Services (Houston, TX). Sequence analyses and
annotation were performed in Artemis [9]. Open reading frames
were initially defined by Glimmer. Annotations were made where
BLAST e-values equaled or approached zero and there was 98%
or greater identity at the nucleotide and amino acid levels. Direct
and inverted repeats were identified by dot-plot analysis of
pairwise FASTA alignments made using the BLAST suite. Open
reading frame (Orf) and feature plots were prepared using Artemis
and DNAPlotter [10]. Orf identify was determined using BLAST
and Pfam [11,12]. Multiple sequence alignments were performed
using Clustal and dendograms were computed using a Jones-
Taylor-Thornton (JTT) model in MEGA5 [13].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing by disc diffusion was
performed using the Clinical and Laboratory Standards Institute
(CLSI, formerly NCCLS) [14]. Antimicrobial discs and control
strain E. coli ATCC 35218 were obtained from Remel. The
antimicrobial discs used contained ampicillin (10 mg), streptomycin
(10 mg), trimethoprim (5 mg), tetracycline (30 mg), nalidixic acid
(30 mg), chloramphenicol (30 mg), ciprofloxacin (5 mg) and sul-
phonamide (300 mg). Inhibition zone diameters were interpreted
in accordance with CLSI guidelines with WHONET software
version 5.3 [15]. Minimum inhibitory concentrations (MICs) to
nalidixic acid were measured by the E-test (Biomerieux), in
accordance with manufacturer’s instructions and by the broth
dilution technique in Mueller-Hinton broth as recommended by
the CLSI and using E. coli ATCC 35218 as control [16].
In vitro conjugation
In vitro conjugation experiments were performed by solid and
liquid mating. Donors and recipients were cultured in LB with
appropriate selective antimicrobials. For liquid mating, 50 ml and
200 ml of mid-logarithmic phase LB cultures from donor and
recipient respectively were mixed in 1 mL of LB, pre-warmed to
37uC. After one hour mating at 37uC, the cells were placed on ice
to terminate the reaction. For solid mating, 0.5 mL of donor and
recipient culture, grown overnight with selection, was spun down
gently and resuspended in 20 ml of LB without antibiotics. The
suspension was spotted onto dried LB plates, allowed to dry at
room temperature for 15 minutes and then incubated at 37uC for
three hours or overnight. The mating reaction was resuspended in
1 ml of LB with vortexing and placed on ice to terminate
conjugation. After mating, serial ten-fold dilutions of each
terminated reaction was made in cold phosphate buffered saline
and plated onto plates containing tetracycline (or other appropri-
ate antimicrobials for controls) to select for the plasmid and
nalidixic acid, resistance to which is conferred chromosomally in
the recipient. Transconjugant colonies were counted after
overnight incubation at 37uC and verified by plasmid profiling,
phenotype on MacConkey and Eosin methylene blue agars, PCR-
RFLP for the fliC allele [17], and PCR for donor- and recipient-
specific markers. Viable counts of donors and recipient were also
performed. The number of transconjugant colonies per donor
Table 1. Strains used in this study.
Genotype and description Reference or Source
09/22a qnrS1-positive E. coli isolate from Nigeria [5]
DH5a F– ø80dlacZDM15 D(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK– mK+) phoA supE44 l– thi-1 gyrA96 relA1 Invitrogen
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) o¨80lacZDM15.lacX74 deoR recA1 araD139 D(ara-leu)7697 galU galK rpsL
(StrR) endA1 nupG
Invitrogen
C600 NalR Nalidixic acid-resistant derivative of C600. [47]
SM10 lpir lpir E. coli strain harboring an inc-P conjugation system in the chromosome [35]
UMN026 Uropathogenic E. coli strain bearing IncP and IncX1 plasmids [36]
NCTC 10418 Susceptibility testing control
ATCC 35218 Susceptibility testing control
LMG194 F-.lacX74 gal E thi rpsL.phoA (Pvu II).ara714 leu::Tn10 Invitrogen [48]
EC1502 Rifampicin resistant E. coli strain University of Bradford
J53 F2 met pro Azir [49]
doi:10.1371/journal.pone.0110279.t001
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colony-forming units was computed as the plasmid transfer
efficiency [18].
Plasmid stability
We serially passaged pEBG1 in its source strain, 09/22a and in
DH5aE essentially as described by Sandegren et al [19]. Triplicate
starting cultures were grown overnight at 37uC in 1 mL of LB
supplemented with tetracycline (25 mg/L). Bacterial cells were
washed by spinning down overnight cultures and resuspending the
pellet in 1 mL of LB without antibiotics. An aliquot of 100 mL of
washed cells was transferred into 1 mL of LB and incubated
overnight at 37uC. Serial passaging of 100 mL of overnight culture
to 1 mL of LB was performed daily, approximating 10 generations
of growth per passage. Every 20 generations (48 hours), samples
were diluted and plated on MacConkey and tetracycline plates.
Once counts began to drop off, colonies were screened through
replica plating on plates containing tetracycline, trimethoprim and
ciprofloxacin to confirm that cells lost the plasmid.
Results
Quinolone-non-susceptible strain 09/22a from Nigeria
carries its qnrS1 gene on an IncX plasmid
Strain 09/22a is a quinolone-non-susceptible E. coli isolate from
Nigeria that tested positive for qnrS1 by PCR in a recent study [5].
The strain was unable to conjugate quinolone resistance to E. coli
C600, TOP10 or EC1502. We therefore extracted plasmids from
09/22a by boiling and electroporated the extract into electro-
competent E. coli DH5aE (Invitrogen). Selection on nalidixic acid
plates (100 mg/mL) yielded no transformants. Selection on plates
containing 1 mg/mL of ciprofloxacin produced transformants
resistant to ciprofloxacin, trimethoprim and tetracycline, all of
which carried a single large plasmid. The plasmid, termed pEBG1,
Table 2. Oligonucleotide primers used for PCR.
Target gene Sequences Application Reference
topB F 5’ AGACTCTTTATTGCTGAAAAACCATC 3’; R 5’ TTTTTTAGCGAATTC-
AAAACCTATTTTT 3’
Amplification of topB from pEBG1
for cloning into pBAD/Thio-TOPO
This study
fliC F 5’ ATGGCACAAGTCATTAATACCCAAC 3’; R
5’ CTAACCCTGCAGCAGAGACA 3’
fliC PCR-RFLP [17]
qnrS F 5’ CAATCATACATATCGGCACC 3’; R 5’ TCAGGATAAACAACAATACCC 3’ Amplification of qnrS1 [28]
IncX1 (taxC) F 5’ GCTTAGACTTTGTTTTATCGTT 3’; R 5’ TAATGATCCTCAGCATGTGAT 3’ Amplification of taxC from IncX1
plasmids
[20]
IncX2 (taxC) F 5’ GCGAAGAAATCAAAGAAGCTA 3’; R 5’ TGTTGAATGCCGTTCTTGTCCAG 3’ Amplification of taxC from IncX1
plasmids
[20]
qnrS1comp F 59 TGAGGGGTTGTAATGTGTTGAT 39; R 59 TGCAAGGTTGACAATATTATTCGTTTT 39 Cloning qnrS1 This study
BlpIFrag F 59 AGTTGTTCCTCATGAG 39; R 59 ACTGACTGTCTTTGTATCA 39 Verifying qnrS1 deletion This study
BlpI-2 F 59 ATTCGCAGCGACTTTCGACGT 39; R 59TTCCGGTATCCGGGCTTCGGGTG 39 Verifying qnrS1 deletion This study
pilX2 F 59 ACCCTGTCTGTCTTCATGGC 39; R 59 ACCAGTTCGGCAGATAAGGC 39 Amplification of pilX2 from IncX
plasmids
This study
pilX8 F 59 GCACTTAATGCCGCTCTTCC 39; F 59 CCTGTACTGTTGCCGTTTGC 39 Amplification of pilX8 from IncX
plasmids
This study
doi:10.1371/journal.pone.0110279.t002
Table 3. Plasmids used in this study.
Plasmid Description Size Reference or source
pEBG1 WT qnrS1-containing plasmid derived from E. coli strain 09/22a, confers
resistance to ciprofloxacin, tetracycline and trimethoprim
43,530bp This study
pETS4 pEBG1 plasmid with excised region containing qnrS1 41,387 This study
pINK2002 qnrS1 cloned into the Tet gene of pACYC184 5,038 bp This study
pETStop3 Expression vector (pBAD/Thio-TOPO vector) containing a topB insert 6,773 bp This study
pBAD/Thio-TOPO Arabinose inducible expression vector 4,454 bp Invitrogen
p1ECUMN IncP plasmid derived from E. coli strain UMN026 122,302 bp [36]
p2ECUMN IncX1 plasmid derived from E. coli strain UMN026 33,809 bp [36]
pMG306 Naturally occurring qnrS1-bearing plasmid from a Salmonella isolate [32]
pMB2 Naturally occurring aac(69)-Ib-cr-bearing plasmid 125 Kb This study
pMB80-2 Naturally occurring conjugative plasmid from enteropathogenic E. coli strain .100 Kb [34]
pGEM-T AmpR; TA-cloning vector 3,000 bp Promega
pACYC184 Tet and Cm resistant cloning vector 4,244 bp NEB
doi:10.1371/journal.pone.0110279.t003
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was purified and shot-gun sequenced. pEBG1 was found to be to
be 43,534 bp, with an overall G+C content of 46.72%. Its
sequence has been deposited in Genbank (Accession number
KF738053). pEBG1 is most similar to IncX2 plasmid pNGX2-
QnrS1(Genbank accession no. JQ269335) [20] and the two
plasmids have 100% identical taxC genes. (IncX plasmids are sub-
classified based on TaxC, which agrees with subclassifications
based on polymorphic sites across whole plasmid sequences [20]).
All other taxC genes are less than 90% identical to those of pEBG1
and pNGX2-QnrS1 and therefore pEBG1 is an IncX2 plasmid
(Figure 1). The IncX2 plasmids demonstrate significant homology
to other IncX plasmids, including the prototype R6K, with the
most similarity occurring in the conjugative pilus operon [21].
As was pEBG1, pNGX2-QnrS1 was isolated in western Nigeria
(Genbank accession no. JQ269335) [20] and the two plasmids
currently represent the only completely sequenced IncX2 plasmids
in the database. 71% of pEBG1 is 99% identical to 90% of
pNGX2-QnrS1 and both plasmids carry the qnrS1 gene
(Figure 2). The backbones, including the region encoding the
conjugation system, are nearly identical between the two plasmids,
strongly suggesting that they share a recent ancestor. Their
resistance modules are integrated at the same site butas shown in
Figure 2, the plasmids diverge in the predicted mobile elements
and resistance genes they carry and their resistance modules, based
on the orientation of the qnrS1 gene, are inserted in opposite
orientations.
Like other IncX plasmids, pEBG1 contains alpha and beta
origins of replication, and carries the necessary genes to facilitate
plasmid replication and partition: p1, a replication initiation
protein, ddp3, a DNA distortion polypeptide which alters the
topology of the DNA to allow for transcription initiation (similar to
taxA and taxC), and parA and parG which are plasmid partition
proteins involved in segregation and stability [21]. As shown in
Figure 3, the pEBG1 plasmid backbone contains all other core
genes common to IncX plasmids, in the following order: taxA,
encoding a DNA-distortion polypeptide, which is necessary for
altering the DNA helix of plasmids that contain two replication
origins [22]; taxC, encoding a relaxase required for replication and
conjugative transfer of the plasmid [21]; actX, containing a NusG
transcription termination motif and probably the last gene in that
operon; the IncX-type pilus synthesis operon (pilX1-pilX11);
putative relaxase, taxB; and putative nuclease parB. pEBG1
contains an IS3 element in its pilus synthesis operon between
pilX5 and pilX6. This insertion sequence is not present in
pNGX2-QnrS1 (Figures 2a and 3).
pEBG1 also carries open reading frames (orfs) not found in all
IncX plasmids, including orfEBG036, predicted to encode a H-
NS histone family protein, EBG071c, predicted to encode a PecM-
like membrane protein associated with the tetAR genes, and a
putative DnaJ-domain protein that is 39% similar to the N-
terminal J-Domain of the E. coli heat-shock chaperone DnaJ/
Hsp40. DnaJ-domain proteins are often encoded on plasmids,
including pNGX2-QnrS1, but their function in this context is
unknown. The function of the putative ABC transporter permease
(PecM)-like protein is also unknown. Proteins belonging to this
family are involved in small molecule efflux. Plasmid-borne H-NS
family proteins are known to compete with chromosomal H-NS,
reducing repression of A-T rich sequences present on the plasmid
[23]. (The region containing the 657 bp qnrS1 orf and 570 bp of
intergenic sequence upstream, conserved among qnrS1-bearing
plasmids, has a GC% of 44.42%, compared to 46.72% for the
whole plasmid and 50.8% for the E. coli chromosome [24]).
Another gene found on pEBG1, which is also found in many, but
not all, other IncX-type plasmids, is the 2.3 Kb topB, coding for
bacterial type III topoisomerase. topB is truncated at the 59 end in
pNGX2-QnrS1 by an antimicrobial resistance gene module but
pEBG1 contains a full-length gene. Type III topoisomerases
decactenate DNA during replication [25] but the function of
plasmid-encoded topB genes, which are only partially conserved,
has not been elucidated.
pEBG1 confers resistance to trimethoprim, tetracycline and the
quinolones. The plasmid’s trimethoprim resistance gene, dfrA14,
probably originated in a class 1 integron. The 59 end of this
integron, including the intI1 gene is intact. The integron also
includes a truncated aadA gene. The 39 end of the integron is
truncated by an IS26 element that is 99% identical to the element
downstream of qnrS1. Although both carry qnrS1, the region
containing the dfrA14 gene is not present on the similar plasmid
Figure 1. a. Maximum likelihood dendogram depicting evolutionary relationships among TaxC sequences from 12 IncX plasmids,
including representatives from groups defined from whole plasmid polymorphisms [20] and pEBG1(boxed), the plasmid
sequenced in this study.
doi:10.1371/journal.pone.0110279.g001
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pNGX2-QnrS1, suggesting that it has been recently mobilized,
perhaps via the IS26 element. The resistance module encompass-
ing qnrS1 and its flanking resistance and transposase genes is
nearly identical to that of other plasmids, including E. coli plasmid
pT078 and pKOX105, from a Klebsiella oxytoca strain, with the
important exception that beta-lactamase genes present on these
plasmids are absent in pEBG1 [26,27]. Although the qnrS1
modules of pEBG1 and pNGX2-QnrS1 are identical, the plasmid
backbones are also highly similar, and the two plasmids were
recovered from geographically proximal areas, it is clear that
qnrS1 was acquired independently by each plasmid. The location
of qnrS1 and its flanking IS26 element varies between the
plasmids, being at the 59 end of topB in pNGX2-QnrS1 but with
the resistance region downstream of topB in pEBG1. qnrS1 is
often adjacent to a tnpA transposase in other plasmids, and it has
been hypothesized that the qnrS1 gene is usually part of an IS26
element [28]. IS26 contains two 14 bp perfect terminal repeats.
We identified four IS26-associated inverted repeats [29] adjacent
to the qnrS1 gene. These 14 bp sequences begin at coordinates
23,698, 24,504, 27,142 and 29,074, marking out a putative
transposable element of 5,376 bp encompassing dfrA14 and
qnrS1.
In addition to qnrS1 and dfrA14, pEBG1 also contains the
genes tetR and tetA, which lie adjacent to the pecM-like gene
EBG71 and another tnpA gene in a high G+C content region,
whose collective sequence was also not found on pNGX2-QnrS1
(Figure 2). These genes are bordered by a putative relaxase and
Tn3 transposase, which outline the boundaries of the elevated GC
Figure 2. a. Dot plot of pairwise alignment between incX2 plasmids pEBG1 on the x-axis and pNGX2-QnrS1 on the y-axis. The
plasmids are highly conserved overall but differ in the location and content of their antimicrobial resistance modules. The pEBG1 conjugation system
is interrupted by an IS3 element not present in pNGX2-QnrS1. b. schematic of the resistance regiosn of plsdmifd pEBG1 and pNGX2-QnrS1. qnrS1 is
colored brown and other antimicrobial resistance genes are shaded blue. The flanking core plasmid regions are colored yellow. Note that the
insertions are in diffirent orientations.
doi:10.1371/journal.pone.0110279.g002
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content area, suggesting that the plasmid’s tetracycline resistance
also recently came into the plasmid via a transposable element.
The existence of this module on other resistance plasmids [30],
and its absence from homologous plasmid pNGX2-QnrS1 support
this idea. No other areas of the plasmid show a significant
difference in G+C content, save for the fact that the backbone of
the plasmid has an overall lower G+C content than the rest of the
plasmid (Figure 3).
qnrS1 is the sole quinolone resistance-conferring gene on
pEBG1
pEBG1 encodes a number of hypothetical ORFs as well as
ORFs that could contribute to topoisomerase activity (TopB) or
antimicrobial efflux (PecM-like EBG071c). To verify that qnrS1 is
the only quinolone resistance gene on pEBG1, we deleted the gene
by restricting the plasmid with BlpI (which cuts at positions 28,514
and 30,657 in our annotation effectively removing 2,143 bp,
which includes the 39 half of qnrS1 as well as two other
hypothetical orfs, Figure 3). The resulting plasmid, pETS4 was
confirmed by PCR analysis with the qnrS1F and R primer pair
and restriction analysis with NruI, which has 10 sites in pEBG1
including a site at position 30,368, within the deleted region.
pETS4 conferred a six-fold lower MIC to ciprofloxacin than
pEBG1 on DH5a and a greater than 32-fold lower MIC on
TOP10. Resistance was restored upon trans-complementation
with qnrS1 clone pINK2002. Deleting qnrS1 from pEBG1
however produced little effect (about 2–3 fold) on MICs to
nalidixic acid. We then determined the level of resistance
conferred by aac(69)-Ib-cr, a gene that confers ciprofloxacin
resistance but not resistance to other quinolones [31], using
plasmid pMB2, which carries this gene and no other known
plasmid-mediated quinolone resistance gene. We found that
pMB2 provided no significant alteration to the nalidixic acid
MIC of DH5a, but increased resistance to ciprofloxacin three-fold.
As qnrS1 has previously been reported to confer significant
resistance to multiple quinolones, including nalidixic acid, we
additionally tested pMG306, a qnrS1-bearing plasmid isolated
from non-typhoidal Salmonella [32]. As in the original report
describing the plasmid [32], we confirmed that this plasmid
conferred only a slightly greater level of resistance on TOP10,
compared to pEBG1, and that ciprofloxacin resistance was
increased over 10-fold in contrast to four-fold increase in nalidixic
acid resistance. Similar results were seen with this plasmid in the
DH5a andJ53 backgrounds. Thus qnrS1 principally confers
ciprofloxacin resistance. In addition to demonstrating the pivotal
role that qnrS1 plays in ciprofloxacin resistance, these data
Figure 3. Circular map of pEBG1. and BlpI restriction sites conjugation genes are yellow and those that are predicted to encode proteins involved
in DNA mobility or transposition are pink. Orange colored genes are involved in plasmid maintenance; other predicted open reading frames colored
brown and hypothetical open-reading frames are colored light blue. Predicted OriT sites are marked as heavy dark brown lines. Thin black lines
indicate the positions of IS26 repeats.
doi:10.1371/journal.pone.0110279.g003
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demonstrate that the host background is an important determinant
of the effect of qnrS1 (Table 4).
topB is a large, partially conserved gene that is present in most
IncX plasmids, but the function of plasmid-encoded topoisomer-
ases is unknown. Chromosomally encoded DNA gyrase and
topoisomerase are the normal targets of the quinolones. While
topB genes, encoding type III topoisomerases, should not normally
be inhibited by antibacterial quinolones, which are better
inhibitors of type II topoisomerases, bacterial topB genes have
not previously been evaluated in this regard. Since over-expression
of chromosomal topoisomerases can compensate for absence of
gyrase [25], it is possible that plasmid-encoded TopB could confer
resistance to the quinolones by supplementing the activity of
inhibited chromosomal topoisomerases. As it is possible that topB
is not expressed under conditions we used to test for quinolone
resistance in vitro, we cloned the gene and placed it under the
control of the arabinose promoter, using the vector pBAD/Thio-
TOPO (Invitrogen). The resulting clone, pETS-Topo3 produced
copious amounts of the TopB protein when induced with 0.2%
arabinose. Expression was abrogated in the presence of 2%
glucose (data not shown). MICs of the clone to nalidixic acid and
ciprofloxacin were identical in arabinose and glucose, confirming
the topB is not sufficient to confer quinolone resistance. Because it
is known some topB alleles can promote homologous recombina-
tion by stabilizing and resolving Holliday junctions [33], we
hypothesized that topB might enhance mutation rates and that this
might serve as a mechanism of evolution to antimicrobial
resistance by strains carrying IncX plasmids like pEBG1.
However, tests with the pETS-Top3 clone in a TOP10 and
LMG194 background did not reveal enhanced mutation rates
leading to resistance to rifampicin determined by plating cultures
on LB plates containing 50 mg/mL rifampicin (data not shown).
pEBG1 is mobilizable but not self-transmissible
We performed conjugation experiments on solid and in liquid
media, using pMB80-2 as a control plasmid [34]. We were unable
to conjugate pEBG1 into any of three recipient strains, C600,
TOP10 or EC1502 even when mating was extended to 24 h. To
determine whether pEBG1 could be mobilized in vitro, we
electroporated it into strains carrying self-transmissible conjuga-
tion systems. Strain SM10, which contains conjugation genes from
the broad host range IncP-type plasmid RP4 integrated into its
chromosome [35] was unable to mobilize pEBG1. We then
transferred two plasmids, IncP plasmid p1ECUMN and IncX1
plasmid p2ECUMN, from UMN026 [36], into C600 (NalR) by
conjugation. The presence of both plasmids in strain C600 was
confirmed by plasmid profiling and PCR. C600 (p2ECUMN,
p1ECUMN, pEBG1) could mobilize pEBG1 into TOP10
(StrepR). The conjugation rate for pEBG1 after a 3-hour mating
was 1.761023. At 24 hours it was 3.3861027.
Other qnrS1-bearing isolates from Western Nigeria carry
non-identical plasmids
We screened genomic DNA from other qnrS1-bearing isolates
recovered in the same study for pEBG1 plasmids. All these strains
show lowered susceptibility to ciprofloxacin but only one meets the
CLSI breakpoint criteria for resistance. The strains were screened
using taxC-based primers designed by Johnson et al (2012) [20], as
well as primers specific for qnrS1, topB, pilX2 and pilX8. As
shown in Table 5, all five pEBG1 markers were detected in
another strain isolated from the same individual but not in the
other isolates. As we were able to obtain two or more of the
pEBG1 marker amplicons from three other strains, we screened
them for the IncX1 taxC gene and found that only two strains,
including 09/22a carried IncX1 plasmids.
Table 4. MICs to quinolones conferred by pEBG1, its derivatives and other Qnr-encoding plasmids.
Strain Resistance to non-quinolone antimicrobials Nalidixic acid MIC Ciprofloxacin MIC
09/22a Amp Chl Str Sul Tet Tmp 12 0.38
C600 - .256 0.5
DH5a - 24 0.032
DH5a (pEBG1) Tet Tmp 12 0.125
DH5a (pETS4) Tet Tmp 6 0.032
DH5a (pETS4, pINK2002) Chl Tet Tmp 8 0.016
DH5a (pETS4, pACYC184) Chl Tet Tmp 6 0.008
DH5a (pMG306) Chl 24 0.25
DH5a (pMB2) Tet Tmp 24 0.094
TOP10 Str 0.75 ,0.002
TOP10 (pEBG1) Str Tet Tmp 2 0.064
TOP10 (pETS4) Str Tet Tmp 0.75 ,0.002
TOP10 (pETS4, pINK2002) Chl Str Tet Tmp 1 0.016
TOP10 (pETS4, pACYC184) Chl Str Tet Tmp 0.75 ,0.002
TOP10 (pMG306) Chl 3 0.19
J53 Azi 4 0.008
J53 (pMG306) Azi Chl 24 0.75
J53 (pMG282) Azi Chl Str 16 0.38
doi:10.1371/journal.pone.0110279.t004
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pEBG1 is propagated in the medium term without
selection
We studied the stability of pEBG1 following serial passage.
pEBG1 was stably inherited by its original host strain 09/22a and
by DH5a for over 200 generations without selection (Figure 4).
However, extended subculture lead to a significant proportion of
those lines loosing the plasmid.
Discussion
Plasmids harboring qnrS genes tend to be on average smaller
than plasmids carrying other qnr subtypes, and are less likely to be
self-transmissible [1,37]. They vary greatly, belonging to N, L, M,
H, R and X incompatibility groups and residing in diverse
enterobacterial genera [22,37]. Multiple studies have also noted
that qnrS1 tends not to be associated with integrons, and are
instead associated with tnpA transposase genes, which likely
contribute to intermolecular mobility [22,28,38].
In this study, we sequenced and functionally characterized a
qnrS1-bearing plasmid obtained from an E. coli isolate in south-
west Nigeria. At the time of isolation, qnrS1 was the sole plasmid-
encoded quinolone resistance gene identified in that locality and
since the isolates were not clonal, we hypothesized that one or a
few plasmids might account for the recently emerged quinolone
resistance seen in the community. We identified and characterized
pEBG1, a 43.5 Kb IncX2 plasmid. We find that other strains from
Nigeria carry similar plasmids but that pEBG1 does not appear to
have clonally expanded.
The IncX2 plasmid we characterized carries, in addition to
qnrS1, genes conferring resistance to tetracycline and trimetho-
prim. The resistance gene repertoire is the most common variable
among qnrS1-bearing IncX plasmids in and beyond Nigeria. This
finding is worrisome, since it suggests that IncX backbones may be
good scaffolds for incorporating new resistance genes. For
example, in addition to plasmid-encoded quinolone resistance
genes, extended-spectrum beta-lactamase genes have also been
recently found on IncX plasmids [39,40]. Although the plasmid
we identified in this study was from a human isolate, IncX
plasmids, including one IncX2 plasmid, bearing qnrS1 have also
been found in isolates from migratory birds in Europe [41] and
pNGX2-QnrS1 is a poultry isolate, pointing to possible animal
reservoirs and global reach of these elements.
Qnr proteins confer low-level resistance by altering the
interaction between the quinolones and their targets. What is
known about Qnr function and spectrum has been gleaned from
mechanistic studies with QnrA and QnrB. In this study, we found
that qnrS1 from pEBG1 conferred significant fluoroquinolone but
only modest quinolone resistance on laboratory E. coli isolates.
The finding that qnrS1 confers ciprofloxacin non-susceptibility but
very little nalidixic acid resistance on these strains is not wholly
surprising since a previous study has indicated that qnrS1 gene
products sometimes confer no nalidixic acid resistance [42]. A
separate study found that qnrS confers moderate nalidixic acid
and ciprofloxacin resistance in E. coli strain HB101, but confers
no resistance at all in Shigella strains [43]. The qnrS1 gene was
originally reported from a 47 Kb conjugative plasmid, pAH0376,
from Japan in 2005 [43]. The plasmid was reported to confer on
E. coli HB101 resistance to nalidixic acid (MIC, 16 mg/mL) and
ciprofloxacin (MIC, 0.25 mg/mL). The following year, plasmid-
borne qnrS1 was reported from Germany and although the
responsible plasmid pINF1 was not identical to pAH0376, the
qnrS1 genes on both plasmids were flanked by a Tn3 transposon
carrying a blaTEM-1 gene. Other contexts for qnrS1 have since
been described [37,41,42]. Most of these reports demonstrate that
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qnrS1 confers low- to intermediate resistance to ciprofloxacin
(0.25–0.5 mg/mL). Altogether, the findings of this and earlier
studies indicate that the nature and degree of quinolone resistance
conferred by qnrS1 is dependent on host strain background [42].
In Nigeria, most of the quinolone resistance selective pressure
comes from ciprofloxacin, as in Vietnam [37], where qnrS1 is also
highly prevalent, and it therefore makes sense that genes
preferentially conferring resistance to this agent will be selected.
This research, along with work from other laboratories [20,44],
points to multiple instances of qnrS1-bearing IncX plasmids in
Nigeria. In this study, we determined that plasmid pEBG1 is
highly mobilizable, though not self transmissible. The model IncX
plasmid R6K is reported to conjugate at a rate of 1.761023 into
E. coli strain MC1061 [45], the same as the mobilization rate for
pEBG1. The most likely explanation for the inability of pEBG1 to
mediate its own conjugation is the insertion of an IS3 element
between pilX5 and pilX6. Although this element does not disrupt a
gene, it does interrupt the pilX operon and is likely polar on
downstream genes. As the IS3 element is absent from pNGX2-
QnrS1, we anticipate that self transmissible IncX plasmids are also
in circulation in Nigeria. Resistant strains in Nigeria frequently
carry multiple plasmids [46]. Therefore the lack of a fully
functional conjugative system is unlikely to greatly compromise
the success of this qnrS1-bearing plasmid as long as it remains
mobilizable. Overall, the high transmission rate and modular
content observed by us and others [20,45] illustrates that IncX
plasmids are good candidates for mediating the dissemination of
resistance genes. pEBG1 was stably inherited without selection in
the medium term but was lost after 16–18 passages. This suggests
that IncX2 plasmids bearing qnrS1 may be maintained by
antibacterial drug selection and therefore their frequent occur-
rence in Nigeria may be linked to overuse of antibacterial drugs
there, among which ciprofloxacin, trimethoprim and tetracycline
are prominent.
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